Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | OGA | O60502 | 9/20 | 0.36 |
| ▸ | CXCR3 | P49682 | 4/20 | 0.34 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4682563 | 0.99 | CYP2D6 (0.51) | CYP2D6OGACXCR3CHRM5MCHR1 | |
| SCHEMBL4683149 | 0.93 | CYP2D6 (0.61) | CYP2D6CXCR3CHRM5MCHR1MAPK14 | |
| SCHEMBL4678736 | 0.93 | CYP2D6 (0.53) | CYP2D6OGACXCR3MCHR1MAPK14 | |
| Hydrochloric Acid SCHEMBL4685333 | 0.92 | CYP2D6 (0.60) | CYP2D6CXCR3CHRM5MCHR1MAPK14 | |
| Hydrochloric Acid SCHEMBL4682541 | 0.92 | CYP2D6 (0.59) | CYP2D6OGACXCR3CHRM5MCHR1 | |
| SCHEMBL4679386 | 0.86 | CYP2D6 (0.70) | CYP2D6CXCR3CHRM5MCHR1MAPK14 | |
| Hydrochloric Acid SCHEMBL4683742 | 0.85 | CYP2D6 (0.69) | CYP2D6CXCR3CHRM5MCHR1MAPK14 | |
| Hydrochloric Acid SCHEMBL4685784 | 0.85 | CYP2D6 (0.69) | CYP2D6CXCR3CHRM5MCHR1MAPK14 | |
| SCHEMBL4682534 | 0.83 | CYP2D6 (0.56) | CYP2D6CHRM5MEN1KMT2ATSHR | |
| SCHEMBL4686155 | 0.83 | TSHR (0.39) | CYP2D6KMT2AHRH3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1058680-B1 | 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2008-07-09 | — | — | EP | claimed |
| US-6319920-B1 | MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY | SYNTEX (U.S.A.) LLC | 2001-11-20 | — | — | US | claimed |
| EP-1058680-B1 | 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | HOFFMANN LA ROCHE (CH) | 2008-07-09 | — | — | EP | disclosed |
| US-6319920-B1 | MUSCARINIC RECEPTOR ANTAGONIST USED IN GASTROINTESTINAL, GENITOURINARY TRACT, RESPIRATORY TRACT, CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM DISORDERS AND IN ANESTHESIOLOGY AND OPHTHALMOLOGY | SYNTEX (U.S.A.) LLC | 2001-11-20 | — | — | US | disclosed |
| EP-1058680-A1 | 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2000-12-13 | — | — | EP | disclosed |
| WO-1999043657-A1 | 2-ARYLETHYL-(PIPERIDIN-4-YLMETHYL)AMINE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 1999-09-02 | — | — | WO | disclosed |